Learn More

Accuracy. Relevancy. Predictability. Viability. These are the cornerstones of our patient-derived xenograft (PDX) models.

Ready to take the next step and learn more about how you can leverage the attributes of the Champions Oncology’s PDX platform for your drug development program?

Simply complete the form below to contact us today and a member of the Champions Oncology team will be in touch within one business day.

Champions Oncology - Specializing in | Personalized Cancer Therapy | Translational Oncology Solutions | Oncology drug development | Oncology drug discovery | Translational oncology | Translation oncology research | Predictive oncology | Patient-derived xenograft model | Tumorgrafts | Alternative/new cancer treatment | Anticancer therapies | Personalized cancer treatment | Personalized cancer therapy | Personalized oncology